Joubert syndrome 27 is a rare genetic condition that affects brain development and body coordination. People with Joubert syndrome 27 often have low muscle tone, delayed milestones, breathing pattern changes, and eye or balance problems. Signs usually appear in infancy and can be lifelong, but not everyone will have the same experience. Care focuses on therapies, supportive care, and managing features like breathing or kidney issues, and advances in care mean people often manage well with treatment. If you or a loved one is facing Joubert syndrome 27, talking with your healthcare provider can bring clarity and reassurance.
Overview
Joubert syndrome 27Symptoms
Early signs of Joubert syndrome 27 often include weak muscle tone in infancy, breathing irregularities, and unusual eye movements. Many later show balance and coordination problems, delayed milestones, and learning differences. Some have vision, kidney, or liver issues.
Outlook and prognosis
Many living with Joubert syndrome 27 grow and learn at their own pace, with early therapies helping speech, movement, and daily skills. Vision, breathing, and kidney or liver health may need long‑term follow‑up. Life expectancy varies, improving with coordinated, preventive care.
Causes and risk factors
Joubert syndrome 27 is caused by harmful changes in a single cilia-related gene, usually autosomal recessive. Risk is higher when both parents are carriers, with family history, or consanguinity. Environmental factors don’t cause it.
Genetic influences
Genetics are central in Joubert syndrome 27. It results from changes in the CPLANE1 gene and follows an autosomal recessive pattern—most affected people inherit two variants, one from each parent. Genetic testing confirms diagnosis, guides family planning, and supports carrier screening.
Diagnosis
Diagnosis of Joubert syndrome 27 is based on recognizable clinical features and a characteristic brain MRI pattern. Genetic testing panels or exome sequencing then confirm the subtype. Many clinicians refer to this as the genetic diagnosis of Joubert syndrome 27.
Treatment and drugs
Treatment for Joubert syndrome 27 focuses on supportive care tailored to each person’s needs. This can include early physiotherapy and occupational therapy, vision and hearing support, seizure management if needed, and help with breathing or feeding. Regular follow‑up with neurology, nephrology, and developmental teams guides care over time.
Symptoms
Families often notice floppier muscle tone, unsteady movement, or unusual breathing patterns in a baby. For many people with Joubert syndrome 27, eye-movement difficulties, delayed milestones, and coordination challenges shape daily life. Parents sometimes ask about early features of Joubert syndrome 27—these can include irregular breathing in infancy, trouble tracking with the eyes, and slower head control. Doctors may also watch for vision changes and, less often, kidney or liver issues.
Babies may feel floppy when held, and head control can take longer to develop. You might notice small changes at first, like needing extra support when sitting. This low tone can make moving against gravity tiring.
Sitting, crawling, and walking often happen later than in other children. Loved ones often notice the changes first. With practice and therapies, many gain new skills over time.
Movements can be wobbly or shaky, and falls may happen more easily. In daily routines, this might show up as small but noticeable changes. Holding utensils, climbing stairs, or riding a bike can take extra focus.
In infancy, there can be brief pauses in breathing or periods of unusually fast breathing. Early on, this might look like short spells that come and go while awake. These patterns are common in Joubert syndrome 27 and often improve with age.
How people usually first notice Joubert syndrome 27?
Many families first notice Joubert syndrome 27 in infancy when a baby has low muscle tone, seems unusually floppy, has trouble coordinating sucking and breathing, or shows unusual eye movements and delayed head control. Doctors often pick up the first signs of Joubert syndrome 27 during early checkups or imaging, especially if an MRI shows the characteristic “molar tooth sign” in the brainstem and cerebellum that helps explain balance and coordination problems. Sometimes clues appear even earlier on prenatal ultrasound or fetal MRI, such as abnormal brain development, prompting closer follow-up after birth to confirm how Joubert syndrome 27 is first noticed.
Types of Joubert syndrome 27
Joubert syndrome 27 is one of several genetic subtypes within the broader Joubert spectrum, and the exact gene involved helps define the variant and how it shows up day to day. People with Joubert syndromes share a core brain finding and usually similar early symptoms, but differences in the gene can shift how severe movement, vision, kidney, liver, or breathing issues are. Not everyone will experience every type. When people talk about types of Joubert syndrome, they often mean which gene subtype is involved and the pattern of features linked to it.
CPLANE1 (JBTS27)
Often linked with classic Joubert signs such as low muscle tone in infancy, delayed milestones, and the characteristic eye movement and balance problems. Some may also develop kidney or liver involvement over time, so periodic screening is common. Vision issues like retinal changes can occur in a subset.
AHI1 (JBTS3)
Movement and eye tracking problems are common, and learning challenges vary from mild to more pronounced. There is a higher chance of retinal involvement, which may affect night or peripheral vision. Kidney problems are less frequent than in some other subtypes.
TMEM67 (JBTS6)
Often associated with a risk of both kidney cysts and liver fibrosis, sometimes called a kidney–liver form. Balance and eye movement issues occur alongside developmental delays. Regular kidney and liver checks are recommended.
CEP290 (JBTS10)
Frequently tied to retinal degeneration that can progress, sometimes leading to significant vision loss. Developmental and coordination difficulties are typical, and kidney disease can occur in some. Early and regular eye exams help guide support.
OFD1 (JBTS10/OFD1-related)
Can include Joubert features with additional oral, facial, or digital differences like extra or differently shaped fingers or toes. Kidney involvement may occur, and severity can vary by sex because this gene is on the X chromosome. Developmental delays and coordination issues are part of the core picture.
CC2D2A (JBTS9)
Often includes developmental delay, low muscle tone, and eye movement abnormalities. Kidney cysts can develop in some, while others have mainly neurological features. Vision may be affected but is variable.
TMEM216 (JBTS2)
Typically shows early low muscle tone and delayed motor skills with the classic eye movement pattern. Some develop kidney or facial differences, and severity ranges from mild to more complex. Hearing issues are reported in a minority.
KIAA0586 (JBTS23)
Usually presents with coordination and eye movement problems and developmental delays. Skeletal differences like extra fingers or toes can be seen in some. Kidney and liver involvement are less common than in certain other variants of Joubert syndrome.
NPHP1 (JBTS4)
Shares core neurological features with a higher chance of kidney disease similar to nephronophthisis. Vision and liver issues are less prominent here. Growth and energy levels can be affected if kidney disease advances.
TMEM231 (JBTS20)
Presents with balance and eye movement difficulties plus developmental delays. Kidney involvement can occur but is variable. Some individuals have subtle facial features linked to this subtype.
What genetics can tell you about symptoms
Joubert syndrome 27 often causes low muscle tone, breathing rhythm changes, and delayed development because CPLANE1 gene variants disrupt how tiny cell “antennae” (cilia) guide brain and eye development. Specific changes can also affect kidney or liver cilia, leading to cysts or scarring.
Causes and risk factors
The genetic causes of Joubert syndrome 27 are harmful changes in a single gene that disrupt tiny hairlike cell parts called cilia. Some risks are written in our DNA, passed down through families. It is usually inherited in an autosomal recessive way, where both parents carry one gene change and each child has a 25% (1 in 4) chance to be affected. Risk is higher with a known family history, when parents are related by blood, or in groups where a specific gene change is more common. Lifestyle, diet, infections, or medications do not cause Joubert syndrome 27, but early diagnosis and supportive care can influence how severe the features are.
Environmental and biological risk factors
Joubert syndrome 27 is present from birth and appears to stem mainly from internal biology established very early in development. Environmental risk factors for Joubert syndrome 27 are not well established, and most research has not found consistent outside triggers. Being exposed to risks in your body or environment doesn’t mean illness is inevitable.
Joubert syndrome 27 seems driven by body-based factors present from conception. External exposures have not been shown to initiate this condition. Research continues into the exact early developmental steps involved.
No consistent association with Joubert syndrome 27 has been shown. Current evidence does not support a strong effect of older maternal or paternal age.
Conditions like diabetes or thyroid disease can influence fetal development overall. They have not been shown to specifically increase the chance of Joubert syndrome 27. Evidence is limited and not consistent.
Serious infections during pregnancy can affect brain development. No specific infection has been linked to Joubert syndrome 27. Data so far do not show a direct causal connection.
Genetic risk factors
Joubert syndrome 27 is linked to changes in a single gene that helps tiny cell parts called cilia do their jobs. Most children are affected only when they inherit one nonworking copy of this gene from each parent. Some risk factors are inherited through our genes. Even within the same family, features and severity can differ from child to child.
Autosomal recessive: Joubert syndrome 27 usually occurs when a child inherits two nonworking copies of the same gene, one from each parent. This is known as autosomal recessive inheritance.
Carrier parents: Parents are typically healthy carriers with one working and one nonworking copy. When both are carriers, each pregnancy has a 25% chance for Joubert syndrome 27 and a 50% chance for a carrier child.
Compound heterozygosity: A child may inherit two different nonworking changes in the gene linked to Joubert syndrome 27. Even if the changes are not identical, having one from each parent can still cause the condition.
Variant types: Changes that stop the gene from working altogether are common in Joubert syndrome 27. Smaller changes that alter how the gene works can also disrupt cilia function and lead to disease.
Shared ancestry: Parents who are related by blood have a higher chance of carrying the same rare gene change. This increases the likelihood of a child having Joubert syndrome 27.
Founder variants: In some communities, a recurring gene change explains many cases. This can raise the local carrier rate and the chance of Joubert syndrome 27 in that population.
De novo changes: Brand-new changes in a single copy of the gene rarely cause recessive conditions by themselves. A new change can matter if the child also inherits a second nonworking copy from the other parent.
Family history: Having one child with Joubert syndrome 27 raises the chance in future pregnancies if both parents are carriers. Extended relatives may also be carriers without symptoms.
Genetic testing: Panel or exome testing can find the exact gene changes behind Joubert syndrome 27. Genetic testing for Joubert syndrome 27 can confirm the cause and guide carrier testing for family members.
Lifestyle risk factors
Joubert syndrome 27 is a congenital condition; lifestyle habits do not cause it, but they can influence symptoms, function, and complications over time. Thoughtful daily choices can support balance, breathing rhythms, energy levels, and organ health. The points below focus on how lifestyle affects Joubert syndrome 27 and highlight practical areas to consider. This provides context for lifestyle risk factors for Joubert syndrome 27 without implying causation.
Targeted balance, core-strength, and coordination work can improve gait stability and reduce falls related to ataxia. Overexertion or unsafe activities (climbing, uneven terrain) can increase injury risk because of impaired motor control.
Calorie-dense, texture-modified foods and paced feeding can support growth and reduce aspiration in hypotonia and oral–motor incoordination. Poor intake or choking risk can worsen failure to thrive and lead to aspiration pneumonia.
Regular fluid intake can support kidney perfusion if nephronophthisis or renal vulnerability is present. High-sodium or excessively high-protein diets may add renal stress and accelerate fatigue from fluid–electrolyte imbalance.
A consistent sleep schedule and side-sleeping or head-of-bed elevation may lessen central apnea episodes and daytime fatigue. Alcohol or sedative medications can suppress respiratory drive and worsen abnormal breathing patterns.
Risk prevention
There’s no way to prevent Joubert syndrome 27 itself, but you can lower risks of complications and support healthy development. Prevention is about lowering risk, not eliminating it completely. Planning a pregnancy may include genetic counseling and testing options. Acting early when you notice early symptoms of Joubert syndrome 27 can also help doctors watch for treatable issues like breathing, feeding, kidney, or vision problems.
A genetics professional can explain how Joubert syndrome 27 is inherited and what it may mean for your family. They can review test options and help you plan next steps.
If Joubert syndrome 27 is in your family, blood or saliva tests can check who carries the gene change. This can guide family planning and help relatives understand their risks.
Some families consider IVF with embryo testing or prenatal testing to reduce the chance of having a child with Joubert syndrome 27. Your care team can explain timing, accuracy, and limits so you can choose what fits your values.
If a baby shows low muscle tone, unusual eye movements, or irregular breathing, ask for a prompt neurological and developmental check. Early referral helps tailor monitoring for Joubert syndrome 27 complications.
Transmission
Joubert syndrome 27 is not contagious—you can’t catch it from someone else. It is a genetic condition that runs in families, most often in an autosomal recessive pattern, meaning a child inherits one nonworking copy of the gene from each parent, who are usually healthy carriers. When both parents are carriers, each pregnancy has a 25% (1 in 4) chance of a child with Joubert syndrome 27, a 50% (1 in 2) chance the child will be a carrier, and a 25% (1 in 4) chance of neither copy being changed.
Rarely, a new gene change can arise for the first time in a parent’s egg or sperm, which can play a role in how Joubert syndrome 27 is inherited. If there’s a family history or a known variant, carrier screening and genetic counseling can help you understand the genetic transmission of Joubert syndrome 27.
When to test your genes
Consider genetic testing if you have Joubert syndrome 27, features suggestive of Joubert syndrome, or a close relative with a confirmed pathogenic CPLANE1/INPP5E variant. Testing also helps before pregnancy or during family planning to clarify carrier status and recurrence risk. Results can guide surveillance, supportive therapies, and coordination of specialist care.
Diagnosis
Diagnosis of Joubert syndrome 27 usually starts with noticing certain patterns in movement, breathing, and development, then confirming them with targeted tests. Getting a diagnosis is often a turning point toward answers and support. Doctors look for a specific brain MRI pattern and may use genetic tests to confirm the exact subtype, including Joubert syndrome 27. Some findings can appear in infancy, while others become clearer over time, so multiple steps may be involved.
Providers look for low muscle tone, balance and coordination challenges, unusual eye movements, and early breathing irregularities. These patterns raise suspicion for the Joubert spectrum and guide which tests to order. They also help differentiate it from other conditions with similar early symptoms.
Radiologists look for the molar tooth sign, a hallmark change in the midbrain and cerebellum. Seeing this pattern strongly supports the diagnosis of Joubert syndrome 27. MRI also helps rule out other brain conditions.
A multigene panel or exome sequencing looks for changes in genes known to cause Joubert syndromes and can confirm the genetic diagnosis of Joubert syndrome 27. Finding two disease-causing variants in the same gene typically confirms an autosomal recessive form. Results can guide family planning and eligibility for research or trials.
If there is a known familial variant, CVS (chorionic villus sampling) or amniocentesis can test a pregnancy directly for that change. Targeted ultrasound or fetal MRI may show hindbrain differences in higher-risk pregnancies. These approaches are usually coordinated with a maternal–fetal medicine and genetics team.
Stages of Joubert syndrome 27
Joubert syndrome 27 does not have defined progression stages. Different tests may be suggested to help confirm the diagnosis and check for related organ issues. It’s a genetic condition present from birth; abilities can change with growth and therapy, and some related problems (like breathing, eye, kidney, or liver issues) may appear or be found over time, but it doesn’t follow a step-by-step stage pattern. Doctors rely on early symptoms of Joubert syndrome 27, brain MRI findings, and genetic testing, then track progress with developmental checks and regular eye, kidney, and liver evaluations.
Outlook and prognosis
Looking ahead can feel daunting, but many living with Joubert syndrome 27 grow and learn over time with tailored therapies. The early symptoms of Joubert syndrome 27 can range from low muscle tone and delayed milestones to breathing irregularities and feeding challenges in infancy; later on, some people develop coordination issues, vision or hearing differences, kidney or liver involvement, or learning disabilities. Everyone’s journey looks a little different. What this means day to day is that supports often shift with age—early physical and occupational therapy, speech work for language and swallowing, and school accommodations can help kids build skills and independence.
Prognosis refers to how a condition tends to change or stabilize over time. In Joubert syndrome 27, life expectancy varies and is largely shaped by how severe the brainstem and cerebellar differences are and whether organs like the kidneys or liver are affected. Serious breathing instability in infancy can be life‑threatening, and kidney failure later in childhood or adulthood is a major risk for some. That said, many children without major organ complications reach adulthood, attend school, and participate in family and community life with supports in place.
With ongoing care, many people maintain a stable level of function, though some will face new challenges like worsening balance, vision changes, or kidney issues that need closer follow‑up. Regular monitoring—neurology, eye exams, kidney and liver tests, and sleep or breathing checks—helps catch problems early, when they’re easier to manage. Talk with your doctor about what your personal outlook might look like. If a specific gene change has been identified, genetic counseling can clarify inheritance and, in some cases, help estimate risks for organ involvement, though not everyone with the same gene change will have the same outlook.
Long-term effects
For many living with Joubert syndrome 27, long-term features tend to center on movement, learning, vision, breathing, and how the kidneys and liver hold up over time. Long-term effects vary widely, and no two people have the same mix or severity. Some features ease with age, while others—especially organ-related changes—may progress and need lifelong monitoring. Overall outlook often depends most on kidney and liver involvement, and many people live into adulthood.
Ongoing balance and coordination difficulties often persist from childhood into adulthood. Hypotonia in infancy can evolve into ataxia and clumsiness later on. These features may affect walking speed, running, and fine hand tasks.
Intellectual abilities range from typical to mild or moderate challenges. School and work independence vary by individual strengths and supports. Day-to-day problem‑solving may be slower but can be steady over time.
Irregular breathing in newborns often improves after infancy. Some continue to have sleep‑disordered breathing or pauses at night. Daytime breathing is usually stable.
Eye‑tracking can remain slow or jerky, known as ocular motor apraxia, and nystagmus may persist. Some develop retinal degeneration, leading to night vision problems and gradual vision loss. Regular vision checks help clarify changes over time.
How is it to live with Joubert syndrome 27?
Living with Joubert syndrome 27 often means pacing the day around fatigue, balance challenges, and slower processing, while building routines that keep life predictable and safe. Many rely on therapies—physical, occupational, speech—and simple tools like visual schedules, mobility supports, and extra time for transitions to make school, work, and home tasks more manageable. Families, friends, and teachers usually become active teammates, learning how to cue for coordination, simplify instructions, and celebrate steady gains rather than quick leaps. For many, the rhythm is slower but steady, and with accommodations and patient support, daily life can be structured, connected, and meaningful.
Treatment and drugs
Treatment for Joubert syndrome 27 focuses on easing symptoms, supporting development, and preventing complications, since there’s currently no cure. Care is usually coordinated by a team—neurology, genetics, physical and occupational therapy, speech therapy, eye and kidney specialists—based on the person’s specific features. Doctors sometimes recommend a combination of lifestyle changes and drugs, such as medicines to control seizures, sleep or breathing support devices for irregular breathing, glasses or vision therapy for eye movement issues, and targeted care if the kidneys or liver are affected. For many people, treatment begins with small daily steps, like regular therapy sessions to build balance and coordination, adaptive tools at school, and routines that support learning and communication. Keep track of how you feel, and share this with your care team, as treatment plans often change over time with growth, new symptoms, or life transitions.
Non-drug treatment
Non-drug care focuses on building skills, supporting breathing and feeding, and helping families navigate daily life. Non-drug treatments often lay the foundation for progress, even when medicines or surgeries are also part of care. Early symptoms of Joubert syndrome 27 like poor head control and unsteady movements can improve with the right therapies. Plans are tailored over time because needs can change from infancy through school years.
Exercises build core strength, balance, and coordination to ease ataxia and low muscle tone. Therapists often use play-based activities and safe practice to improve walking and endurance. Progress is gradual but meaningful.
Skills for dressing, eating, writing, and play are broken into small, achievable steps. Adaptive tools and home strategies can make daily routines smoother for families living with Joubert syndrome 27. Therapists also work on sensory processing.
Therapy supports speech clarity, understanding, and social communication. If speech is limited, augmentative communication tools (like picture boards or tablets) give a reliable voice. Swallow safety is often assessed.
Techniques improve coordination of suck–swallow–breath and reduce choking or gagging. Positioning, pacing, and texture changes can make meals safer and less tiring. Dietitians help meet growth needs.
Your genes may have an impact on how drugs work for you
Medicines used for Joubert syndrome 27 can work differently depending on your genes, which affect how fast you process a drug and how strongly your cells respond. Pharmacogenetic testing, when available, may guide choices or doses to improve benefit and reduce side effects.
Pharmacological treatments
Medicines for Joubert syndrome 27 focus on easing specific symptoms like seizures, movement or muscle tone issues, reflux, sleep-related breathing problems, and complications in the kidneys or liver. There isn’t a single “disease‑modifying” drug yet, so treatments are chosen based on the features you or your child has. Not everyone responds to the same medication in the same way. For many, getting the right mix helps day-to-day comfort and function, especially when early symptoms of Joubert syndrome 27 include seizures or feeding and breathing difficulties.
Levetiracetam, valproate, and lamotrigine are commonly used to reduce seizures. The choice depends on seizure type, age, and side effects. Your care team may adjust doses over time to find the best control.
Caffeine citrate can help reduce apnea spells in newborns and young infants. It gently stimulates breathing centers in the brain. Monitoring helps keep dosing safe.
Baclofen or tizanidine can relax tight muscles and ease stiffness. Botulinum toxin injections may help a specific tight muscle group. These options can improve comfort and movement.
Propranolol or clonazepam may reduce tremor or sudden movements that get in the way of daily tasks. Benefits and side effects are balanced carefully. Dosing may be increased or lowered gradually to improve control and limit side effects.
Genetic influences
Joubert syndrome 27 is caused by changes in one specific gene that helps tiny cell structures called cilia do their jobs during early development. It’s typically inherited in an autosomal recessive pattern—meaning a child needs to receive two nonworking copies of the gene, one from each parent, who are usually healthy carriers. Family history is one of the strongest clues to a genetic influence. When both parents are carriers, each pregnancy has a 25% (1 in 4) chance of being affected, a 50% (1 in 2) chance the child will be a carrier like the parents, and a 25% chance of inheriting neither change. Even within the same family, features and day-to-day impact can vary because the same gene change can affect people differently. Genetic testing and counseling can confirm the cause, explain results, and guide care and family planning when early symptoms of Joubert syndrome 27 lead to evaluation.
Is Joubert syndrome 27 genetic?
Genetics are central in Joubert syndrome 27. It results from changes in the CPLANE1 gene and follows an autosomal recessive pattern—most affected people inherit two variants, one from each parent. Genetic testing confirms diagnosis, guides family planning, and supports carrier screening.
Pharmacogenetics—how genetics influence drug effects
Treatment for Joubert syndrome 27 is individualized because symptoms and organ involvement vary, so medicines are chosen to manage what’s most relevant for you—such as seizures, sleep or mood concerns, and kidney or liver complications. Genes can influence how quickly you process certain medicines, including some seizure drugs and antidepressants, which can change the dose that works best and the chance of side effects. For example, known gene markers can signal a higher risk of severe skin reactions with carbamazepine in some people of Asian ancestry, or help guide dosing of medicines like phenytoin or clobazam. Pharmacogenetic testing for Joubert syndrome 27 isn’t about the Joubert‑related gene itself; it looks at common drug‑processing genes to help pick safer, more effective options. Kidney or liver issues that can occur in Joubert syndromes, as well as differences in breathing control, also affect how your body handles sedatives and anesthesia, so doctors combine any genetic results with lab tests, organ checks, and careful monitoring. If a medicine isn’t helping or causes side effects, let your care team know so they can adjust the dose, switch drugs, or consider pharmacogenetic testing to better tailor your plan.
Interactions with other conditions
People living with Joubert syndrome 27 often have health issues beyond the brain findings, especially involving the eyes, kidneys, and liver. Doctors call it a “comorbidity” when two conditions occur together. For some, this can mean retinal disease that slowly affects vision, chronic kidney problems that may not show symptoms until later childhood or adolescence, or scarring of the liver that needs regular monitoring. These features overlap with other disorders that affect the same tiny cell structures (cilia), so early symptoms of Joubert syndrome 27 can look similar to related conditions and may change the care plan over time. Breathing problems, including pauses in breathing or sleep apnea, can flare during chest infections and may require extra support during illnesses or anesthesia. When kidney or liver involvement is present, doctors may adjust doses or avoid certain medicines, and coordinated care with eye, kidney, liver, and neurology teams helps many live as fully and safely as possible.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies with unusually low muscle tone, delayed milestones, and a distinctive way of breathing. Families and communities once noticed patterns—an infant who breathed rapidly, then paused, or a child who learned to sit and walk much later than siblings. Eye movement problems, extra fingers or toes, and trouble with balance often stood out in school years, when climbing stairs or navigating uneven ground became hard.
First described in the medical literature as a cerebellar and brainstem disorder in the late 1960s, the core picture was a combination of poor coordination, irregular breathing in infancy, and eye movement difficulties. Over time, descriptions became more precise as brain imaging revealed a hallmark shape on MRI, nicknamed the “molar tooth sign.” This gave doctors a way to group similar cases together and recognize that what families were seeing had a shared root in early brain development.
As medical science evolved, researchers noticed wide variation. Some children had kidney or liver involvement; others had only neurologic features. With each decade, clinicians realized that Joubert syndrome 27 sits within a broader group called ciliopathies—conditions linked to tiny cell structures called cilia that help guide organ and brain development. The idea that a single pathway could explain such different features helped connect earlier, scattered reports.
Advances in genetics then mapped these observations to specific genes. One of these, CPLANE1 (also known as C5orf42), became tied to what’s now called Joubert syndrome 27. Naming subtypes in this way did not change the lived experience overnight, but it did help families get clearer answers and allowed care teams to watch for patterns—like when to screen kidneys or eyes, and what early symptoms of Joubert syndrome 27 might look like in a newborn versus a teenager.
In recent decades, awareness has grown thanks to better MRI access, genetic testing, and international registries. What was once considered rare is now recognized more often, including in communities where access to imaging had been limited. Not every early description was complete, yet together they built the foundation of today’s knowledge. That foundation—clinical observation, careful imaging, and gene discovery—continues to shape practical care: earlier diagnosis, tailored monitoring, and more informed support for people living with Joubert syndrome 27 and their families.